Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Beyond NPM-anaplastic lymphoma kinase driven lymphomagenesis: alternative drivers in anaplastic large cell lymphoma.

Tabbò F, Ponzoni M, Rabadan R, Bertoni F, Inghirami G; European T-cell Lymphoma Study Group.

Curr Opin Hematol. 2013 Jul;20(4):374-81. doi: 10.1097/MOH.0b013e3283623c07. Review.

PMID:
23673339
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Prognostic significance and therapeutic potential of the activation of anaplastic lymphoma kinase/protein kinase B/mammalian target of rapamycin signaling pathway in anaplastic large cell lymphoma.

Gao J, Yin M, Zhu Y, Gu L, Zhang Y, Li Q, Jia C, Ma Z.

BMC Cancer. 2013 Oct 10;13:471. doi: 10.1186/1471-2407-13-471.

PMID:
24112608
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The heat shock protein-90 co-chaperone, Cyclophilin 40, promotes ALK-positive, anaplastic large cell lymphoma viability and its expression is regulated by the NPM-ALK oncoprotein.

Pearson JD, Mohammed Z, Bacani JT, Lai R, Ingham RJ.

BMC Cancer. 2012 Jun 8;12:229. doi: 10.1186/1471-2407-12-229.

PMID:
22681779
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.

Drexler HG, Gignac SM, von Wasielewski R, Werner M, Dirks WG.

Leukemia. 2000 Sep;14(9):1533-59. Review.

PMID:
10994999
[PubMed - indexed for MEDLINE]
5.

Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma.

Bohling SD, Jenson SD, Crockett DK, Schumacher JA, Elenitoba-Johnson KS, Lim MS.

Leuk Res. 2008 Mar;32(3):383-93. Epub 2007 Aug 27.

PMID:
17720243
[PubMed - indexed for MEDLINE]
6.

Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma.

Kutok JL, Aster JC.

J Clin Oncol. 2002 Sep 1;20(17):3691-702. Review.

PMID:
12202671
[PubMed - indexed for MEDLINE]
Free Article
7.

Anaplastic large cell lymphoma, ALK-positive.

Ferreri AJ, Govi S, Pileri SA, Savage KJ.

Crit Rev Oncol Hematol. 2012 Aug;83(2):293-302. doi: 10.1016/j.critrevonc.2012.02.005. Epub 2012 Mar 21. Review.

PMID:
22440390
[PubMed - indexed for MEDLINE]
8.

Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma.

Eckerle S, Brune V, Döring C, Tiacci E, Bohle V, Sundström C, Kodet R, Paulli M, Falini B, Klapper W, Chaubert AB, Willenbrock K, Metzler D, Bräuninger A, Küppers R, Hansmann ML.

Leukemia. 2009 Nov;23(11):2129-38. doi: 10.1038/leu.2009.161. Epub 2009 Aug 6.

PMID:
19657361
[PubMed - indexed for MEDLINE]
9.

HuR-mediated control of C/EBPbeta mRNA stability and translation in ALK-positive anaplastic large cell lymphomas.

Bergalet J, Fawal M, Lopez C, Desjobert C, Lamant L, Delsol G, Morello D, Espinos E.

Mol Cancer Res. 2011 Apr;9(4):485-96. doi: 10.1158/1541-7786.MCR-10-0351. Epub 2011 Feb 22.

PMID:
21343335
[PubMed - indexed for MEDLINE]
Free Article
10.

NPM-ALK and the JunB transcription factor regulate the expression of cytotoxic molecules in ALK-positive, anaplastic large cell lymphoma.

Pearson JD, Lee JK, Bacani JT, Lai R, Ingham RJ.

Int J Clin Exp Pathol. 2011 Jan 30;4(2):124-33.

PMID:
21326808
[PubMed - indexed for MEDLINE]
Free PMC Article
11.
12.

The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulation.

Hübinger G, Scheffrahn I, Müller E, Bai R, Duyster J, Morris SW, Schrezenmeier H, Bergmann L.

Exp Hematol. 1999 Dec;27(12):1796-805.

PMID:
10641597
[PubMed - indexed for MEDLINE]
13.

CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.

Stein H, Foss HD, Dürkop H, Marafioti T, Delsol G, Pulford K, Pileri S, Falini B.

Blood. 2000 Dec 1;96(12):3681-95. Review.

PMID:
11090048
[PubMed - indexed for MEDLINE]
Free Article
14.

Pathobiology of ALK+ anaplastic large-cell lymphoma.

Amin HM, Lai R.

Blood. 2007 Oct 1;110(7):2259-67. Epub 2007 May 22. Review.

PMID:
17519389
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma.

Liu C, Iqbal J, Teruya-Feldstein J, Shen Y, Dabrowska MJ, Dybkaer K, Lim MS, Piva R, Barreca A, Pellegrino E, Spaccarotella E, Lachel CM, Kucuk C, Jiang CS, Hu X, Bhagavathi S, Greiner TC, Weisenburger DD, Aoun P, Perkins SL, McKeithan TW, Inghirami G, Chan WC.

Blood. 2013 Sep 19;122(12):2083-92. doi: 10.1182/blood-2012-08-447375. Epub 2013 Jun 25.

PMID:
23801630
[PubMed - indexed for MEDLINE]
16.

Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma.

Christensen JG, Zou HY, Arango ME, Li Q, Lee JH, McDonnell SR, Yamazaki S, Alton GR, Mroczkowski B, Los G.

Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3314-22.

PMID:
18089725
[PubMed - indexed for MEDLINE]
Free Article
17.

Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway.

Bai RY, Ouyang T, Miething C, Morris SW, Peschel C, Duyster J.

Blood. 2000 Dec 15;96(13):4319-27.

PMID:
11110708
[PubMed - indexed for MEDLINE]
Free Article
18.

Anaplastic large cell lymphoma, ALK-negative.

Ferreri AJ, Govi S, Pileri SA, Savage KJ.

Crit Rev Oncol Hematol. 2013 Feb;85(2):206-15. doi: 10.1016/j.critrevonc.2012.06.004. Epub 2012 Jul 11. Review.

PMID:
22789917
[PubMed - indexed for MEDLINE]
Free Article
19.

Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth.

Riera L, Lasorsa E, Ambrogio C, Surrenti N, Voena C, Chiarle R.

J Biol Chem. 2010 Aug 20;285(34):26441-50. doi: 10.1074/jbc.M110.116327. Epub 2010 Jun 16.

PMID:
20554525
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells.

Shi P, Lai R, Lin Q, Iqbal AS, Young LC, Kwak LW, Ford RJ, Amin HM.

Blood. 2009 Jul 9;114(2):360-70. doi: 10.1182/blood-2007-11-125658. Epub 2009 May 7.

PMID:
19423729
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk